ES2286026T3 - Metodos y dispositivos para eliminar las toxinas nucleofilas del tabaco y del humo del tabaco. - Google Patents
Metodos y dispositivos para eliminar las toxinas nucleofilas del tabaco y del humo del tabaco. Download PDFInfo
- Publication number
- ES2286026T3 ES2286026T3 ES00941705T ES00941705T ES2286026T3 ES 2286026 T3 ES2286026 T3 ES 2286026T3 ES 00941705 T ES00941705 T ES 00941705T ES 00941705 T ES00941705 T ES 00941705T ES 2286026 T3 ES2286026 T3 ES 2286026T3
- Authority
- ES
- Spain
- Prior art keywords
- tobacco
- filter
- smoke
- toxins
- agents
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 241000208125 Nicotiana Species 0.000 title claims abstract description 154
- 235000002637 Nicotiana tabacum Nutrition 0.000 title claims abstract description 154
- 239000000779 smoke Substances 0.000 title claims abstract description 130
- 239000003053 toxin Substances 0.000 title claims abstract description 51
- 231100000765 toxin Toxicity 0.000 title claims abstract description 51
- 108700012359 toxins Proteins 0.000 title claims abstract description 51
- 238000000034 method Methods 0.000 title claims abstract description 31
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 87
- 235000019504 cigarettes Nutrition 0.000 claims abstract description 72
- 230000000269 nucleophilic effect Effects 0.000 claims abstract description 43
- 238000002485 combustion reaction Methods 0.000 claims abstract description 11
- 235000019506 cigar Nutrition 0.000 claims abstract description 4
- 229920002085 Dialdehyde starch Polymers 0.000 claims description 30
- 229920002678 cellulose Polymers 0.000 claims description 19
- 239000001913 cellulose Substances 0.000 claims description 19
- ZNZYKNKBJPZETN-WELNAUFTSA-N Dialdehyde 11678 Chemical compound N1C2=CC=CC=C2C2=C1[C@H](C[C@H](/C(=C/O)C(=O)OC)[C@@H](C=C)C=O)NCC2 ZNZYKNKBJPZETN-WELNAUFTSA-N 0.000 claims description 14
- 229920000642 polymer Polymers 0.000 claims description 13
- 229920000936 Agarose Polymers 0.000 claims description 11
- 125000003172 aldehyde group Chemical group 0.000 claims description 10
- KHIWWQKSHDUIBK-UHFFFAOYSA-N periodic acid Chemical compound OI(=O)(=O)=O KHIWWQKSHDUIBK-UHFFFAOYSA-N 0.000 claims description 10
- 229920002472 Starch Polymers 0.000 claims description 9
- 239000008107 starch Substances 0.000 claims description 9
- 235000019698 starch Nutrition 0.000 claims description 9
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 claims description 4
- 239000000796 flavoring agent Substances 0.000 claims description 3
- 235000019634 flavors Nutrition 0.000 claims description 3
- 239000001254 oxidized starch Substances 0.000 claims description 3
- 235000013808 oxidized starch Nutrition 0.000 claims description 3
- ZWLUXSQADUDCSB-UHFFFAOYSA-N phthalaldehyde Chemical compound O=CC1=CC=CC=C1C=O ZWLUXSQADUDCSB-UHFFFAOYSA-N 0.000 claims description 3
- RGWOFTGZWJGPHG-NKWVEPMBSA-N (2r)-3-hydroxy-2-[(1r)-2-oxo-1-(6-oxo-3h-purin-9-yl)ethoxy]propanal Chemical compound N1C=NC(=O)C2=C1N([C@@H](C=O)O[C@H](CO)C=O)C=N2 RGWOFTGZWJGPHG-NKWVEPMBSA-N 0.000 claims description 2
- 239000002126 C01EB10 - Adenosine Substances 0.000 claims description 2
- 229960005305 adenosine Drugs 0.000 claims description 2
- 150000001875 compounds Chemical class 0.000 abstract description 43
- 230000000391 smoking effect Effects 0.000 abstract description 34
- 239000000126 substance Substances 0.000 abstract description 11
- 238000001914 filtration Methods 0.000 abstract description 6
- 150000001299 aldehydes Chemical class 0.000 description 29
- 239000000463 material Substances 0.000 description 25
- 239000012038 nucleophile Substances 0.000 description 23
- 239000003570 air Substances 0.000 description 19
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 19
- 239000008187 granular material Substances 0.000 description 15
- 230000008030 elimination Effects 0.000 description 13
- 238000003379 elimination reaction Methods 0.000 description 13
- 239000000835 fiber Substances 0.000 description 13
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 12
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 12
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 12
- 230000002411 adverse Effects 0.000 description 12
- 239000011230 binding agent Substances 0.000 description 12
- 235000019505 tobacco product Nutrition 0.000 description 12
- 231100000357 carcinogen Toxicity 0.000 description 10
- 239000003183 carcinogenic agent Substances 0.000 description 10
- 239000012153 distilled water Substances 0.000 description 10
- LELOWRISYMNNSU-UHFFFAOYSA-N hydrogen cyanide Chemical compound N#C LELOWRISYMNNSU-UHFFFAOYSA-N 0.000 description 10
- 231100000331 toxic Toxicity 0.000 description 10
- 230000002588 toxic effect Effects 0.000 description 10
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 9
- 239000011159 matrix material Substances 0.000 description 9
- 238000012360 testing method Methods 0.000 description 9
- 229920002301 cellulose acetate Polymers 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical group CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical group CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 7
- DMVOXQPQNTYEKQ-UHFFFAOYSA-N biphenyl-4-amine Chemical group C1=CC(N)=CC=C1C1=CC=CC=C1 DMVOXQPQNTYEKQ-UHFFFAOYSA-N 0.000 description 7
- 230000009931 harmful effect Effects 0.000 description 7
- 230000014759 maintenance of location Effects 0.000 description 7
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 6
- 230000036541 health Effects 0.000 description 6
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 6
- 239000003471 mutagenic agent Substances 0.000 description 6
- 231100000707 mutagenic chemical Toxicity 0.000 description 6
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 description 6
- 229960002715 nicotine Drugs 0.000 description 6
- -1 radical aldehyde Chemical class 0.000 description 6
- 125000001424 substituent group Chemical group 0.000 description 6
- 229920002261 Corn starch Polymers 0.000 description 5
- 238000002965 ELISA Methods 0.000 description 5
- 239000008120 corn starch Substances 0.000 description 5
- 230000000717 retained effect Effects 0.000 description 5
- 231100000167 toxic agent Toxicity 0.000 description 5
- JBIJLHTVPXGSAM-UHFFFAOYSA-N 2-naphthylamine Chemical compound C1=CC=CC2=CC(N)=CC=C21 JBIJLHTVPXGSAM-UHFFFAOYSA-N 0.000 description 4
- 244000215068 Acacia senegal Species 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- FMMWHPNWAFZXNH-UHFFFAOYSA-N Benz[a]pyrene Chemical compound C1=C2C3=CC=CC=C3C=C(C=C3)C2=C2C3=CC=CC2=C1 FMMWHPNWAFZXNH-UHFFFAOYSA-N 0.000 description 4
- 229920000084 Gum arabic Polymers 0.000 description 4
- 239000000205 acacia gum Substances 0.000 description 4
- 235000010489 acacia gum Nutrition 0.000 description 4
- 239000012080 ambient air Substances 0.000 description 4
- 150000001412 amines Chemical class 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 239000011521 glass Substances 0.000 description 4
- 150000004676 glycans Chemical class 0.000 description 4
- 231100000003 human carcinogen Toxicity 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- UMFJAHHVKNCGLG-UHFFFAOYSA-N n-Nitrosodimethylamine Chemical compound CN(C)N=O UMFJAHHVKNCGLG-UHFFFAOYSA-N 0.000 description 4
- 150000004005 nitrosamines Chemical class 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- 229920003023 plastic Polymers 0.000 description 4
- 239000004033 plastic Substances 0.000 description 4
- 229920001282 polysaccharide Polymers 0.000 description 4
- 239000005017 polysaccharide Substances 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- UHUFTBALEZWWIH-UHFFFAOYSA-N tetradecanal Chemical compound CCCCCCCCCCCCCC=O UHUFTBALEZWWIH-UHFFFAOYSA-N 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 3
- UGFAIRIUMAVXCW-UHFFFAOYSA-N Carbon monoxide Chemical compound [O+]#[C-] UGFAIRIUMAVXCW-UHFFFAOYSA-N 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- 241000282412 Homo Species 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 229920002684 Sepharose Polymers 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 239000003463 adsorbent Substances 0.000 description 3
- 125000003277 amino group Chemical group 0.000 description 3
- 230000004888 barrier function Effects 0.000 description 3
- 230000000711 cancerogenic effect Effects 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 231100000673 dose–response relationship Toxicity 0.000 description 3
- 230000000670 limiting effect Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 230000008018 melting Effects 0.000 description 3
- 238000002844 melting Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 239000000049 pigment Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- DHKHKXVYLBGOIT-UHFFFAOYSA-N 1,1-Diethoxyethane Chemical compound CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 2
- DXBHBZVCASKNBY-UHFFFAOYSA-N 1,2-Benz(a)anthracene Chemical compound C1=CC=C2C3=CC4=CC=CC=C4C=C3C=CC2=C1 DXBHBZVCASKNBY-UHFFFAOYSA-N 0.000 description 2
- YEJRWHAVMIAJKC-UHFFFAOYSA-N 4-Butyrolactone Chemical compound O=C1CCCO1 YEJRWHAVMIAJKC-UHFFFAOYSA-N 0.000 description 2
- HVBSAKJJOYLTQU-UHFFFAOYSA-N 4-aminobenzenesulfonic acid Chemical compound NC1=CC=C(S(O)(=O)=O)C=C1 HVBSAKJJOYLTQU-UHFFFAOYSA-N 0.000 description 2
- HGINCPLSRVDWNT-UHFFFAOYSA-N Acrolein Chemical compound C=CC=O HGINCPLSRVDWNT-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 241000063713 Episema Species 0.000 description 2
- 239000002211 L-ascorbic acid Substances 0.000 description 2
- 235000000069 L-ascorbic acid Nutrition 0.000 description 2
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
- 239000004472 Lysine Substances 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- YFCDLVPYFMHRQZ-UHFFFAOYSA-N N-Nitrosodiethanolamine Chemical compound OCCN(N=O)CCO YFCDLVPYFMHRQZ-UHFFFAOYSA-N 0.000 description 2
- WNYADZVDBIBLJJ-UHFFFAOYSA-N N-Nitrosopyrrolidine Chemical compound O=NN1CCCC1 WNYADZVDBIBLJJ-UHFFFAOYSA-N 0.000 description 2
- WBNQDOYYEUMPFS-UHFFFAOYSA-N N-nitrosodiethylamine Chemical compound CCN(CC)N=O WBNQDOYYEUMPFS-UHFFFAOYSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- HZEBHPIOVYHPMT-OUBTZVSYSA-N Polonium-210 Chemical compound [210Po] HZEBHPIOVYHPMT-OUBTZVSYSA-N 0.000 description 2
- 241000607142 Salmonella Species 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 229910052793 cadmium Inorganic materials 0.000 description 2
- BDOSMKKIYDKNTQ-UHFFFAOYSA-N cadmium atom Chemical compound [Cd] BDOSMKKIYDKNTQ-UHFFFAOYSA-N 0.000 description 2
- 229910002091 carbon monoxide Inorganic materials 0.000 description 2
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 2
- 231100000315 carcinogenic Toxicity 0.000 description 2
- 238000004040 coloring Methods 0.000 description 2
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 238000010348 incorporation Methods 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- AMXOYNBUYSYVKV-UHFFFAOYSA-M lithium bromide Chemical compound [Li+].[Br-] AMXOYNBUYSYVKV-UHFFFAOYSA-M 0.000 description 2
- 231100000053 low toxicity Toxicity 0.000 description 2
- 201000005202 lung cancer Diseases 0.000 description 2
- 208000020816 lung neoplasm Diseases 0.000 description 2
- 231100000219 mutagenic Toxicity 0.000 description 2
- 230000003505 mutagenic effect Effects 0.000 description 2
- 231100000150 mutagenicity / genotoxicity testing Toxicity 0.000 description 2
- 230000035772 mutation Effects 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 239000013618 particulate matter Substances 0.000 description 2
- 239000002953 phosphate buffered saline Substances 0.000 description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000002285 radioactive effect Effects 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- CWERGRDVMFNCDR-UHFFFAOYSA-N thioglycolic acid Chemical compound OC(=O)CS CWERGRDVMFNCDR-UHFFFAOYSA-N 0.000 description 2
- 231100000583 toxicological profile Toxicity 0.000 description 2
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 2
- RUFPHBVGCFYCNW-UHFFFAOYSA-N 1-naphthylamine Chemical compound C1=CC=C2C(N)=CC=CC2=C1 RUFPHBVGCFYCNW-UHFFFAOYSA-N 0.000 description 1
- VPFMJGCHDCVATR-UHFFFAOYSA-N 2,3,4,5,6-pentabromoaniline Chemical compound NC1=C(Br)C(Br)=C(Br)C(Br)=C1Br VPFMJGCHDCVATR-UHFFFAOYSA-N 0.000 description 1
- ILMNSCQOSGKTNZ-UHFFFAOYSA-N 2-[1-(6-aminopurin-9-yl)-2-oxoethoxy]-3-hydroxypropanal Chemical compound NC1=NC=NC2=C1N=CN2C(OC(CO)C=O)C=O ILMNSCQOSGKTNZ-UHFFFAOYSA-N 0.000 description 1
- DZQLQEYLEYWJIB-UHFFFAOYSA-N 4-aminobutanal Chemical compound NCCCC=O DZQLQEYLEYWJIB-UHFFFAOYSA-N 0.000 description 1
- SLXKOJJOQWFEFD-UHFFFAOYSA-N 6-aminohexanoic acid Chemical compound NCCCCCC(O)=O SLXKOJJOQWFEFD-UHFFFAOYSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- NBSCHQHZLSJFNQ-GASJEMHNSA-N D-Glucose 6-phosphate Chemical compound OC1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H](O)[C@H]1O NBSCHQHZLSJFNQ-GASJEMHNSA-N 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 208000001613 Gambling Diseases 0.000 description 1
- VFRROHXSMXFLSN-UHFFFAOYSA-N Glc6P Natural products OP(=O)(O)OCC(O)C(O)C(O)C(O)C=O VFRROHXSMXFLSN-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 108010053070 Glutathione Disulfide Proteins 0.000 description 1
- UGQMRVRMYYASKQ-KQYNXXCUSA-N Inosine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(O)=C2N=C1 UGQMRVRMYYASKQ-KQYNXXCUSA-N 0.000 description 1
- 229930010555 Inosine Natural products 0.000 description 1
- 229910021575 Iron(II) bromide Inorganic materials 0.000 description 1
- 208000019693 Lung disease Diseases 0.000 description 1
- 208000005647 Mumps Diseases 0.000 description 1
- XJLXINKUBYWONI-NNYOXOHSSA-O NADP(+) Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 XJLXINKUBYWONI-NNYOXOHSSA-O 0.000 description 1
- 101710163270 Nuclease Proteins 0.000 description 1
- 229920002873 Polyethylenimine Polymers 0.000 description 1
- 108010077895 Sarcosine Proteins 0.000 description 1
- 229920005654 Sephadex Polymers 0.000 description 1
- 239000012507 Sephadex™ Substances 0.000 description 1
- 208000004509 Tooth Discoloration Diseases 0.000 description 1
- 206010044032 Tooth discolouration Diseases 0.000 description 1
- 150000001241 acetals Chemical class 0.000 description 1
- 229920006221 acetate fiber Polymers 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 229960002684 aminocaproic acid Drugs 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000027455 binding Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 229930188620 butyrolactone Natural products 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 150000001722 carbon compounds Chemical class 0.000 description 1
- 125000003636 chemical group Chemical group 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000001055 chewing effect Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000001212 derivatisation Methods 0.000 description 1
- BADXJIPKFRBFOT-UHFFFAOYSA-N dimedone Chemical compound CC1(C)CC(=O)CC(=O)C1 BADXJIPKFRBFOT-UHFFFAOYSA-N 0.000 description 1
- 238000004980 dosimetry Methods 0.000 description 1
- 239000012039 electrophile Substances 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 229940046149 ferrous bromide Drugs 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000037433 frameshift Effects 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- YPZRWBKMTBYPTK-BJDJZHNGSA-N glutathione disulfide Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@H](C(=O)NCC(O)=O)CSSC[C@@H](C(=O)NCC(O)=O)NC(=O)CC[C@H](N)C(O)=O YPZRWBKMTBYPTK-BJDJZHNGSA-N 0.000 description 1
- 230000013595 glycosylation Effects 0.000 description 1
- 238000006206 glycosylation reaction Methods 0.000 description 1
- 230000008821 health effect Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229940042795 hydrazides for tuberculosis treatment Drugs 0.000 description 1
- 150000002429 hydrazines Chemical class 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 229960003786 inosine Drugs 0.000 description 1
- GYCHYNMREWYSKH-UHFFFAOYSA-L iron(ii) bromide Chemical compound [Fe+2].[Br-].[Br-] GYCHYNMREWYSKH-UHFFFAOYSA-L 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 229940059936 lithium bromide Drugs 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 201000005296 lung carcinoma Diseases 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 229940099596 manganese sulfate Drugs 0.000 description 1
- 239000011702 manganese sulphate Substances 0.000 description 1
- 235000007079 manganese sulphate Nutrition 0.000 description 1
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 230000003228 microsomal effect Effects 0.000 description 1
- 239000003607 modifier Substances 0.000 description 1
- 208000010805 mumps infectious disease Diseases 0.000 description 1
- 231100000299 mutagenicity Toxicity 0.000 description 1
- 230000007886 mutagenicity Effects 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- XKABJYQDMJTNGQ-VIFPVBQESA-N n-nitrosonornicotine Chemical compound O=NN1CCC[C@H]1C1=CC=CN=C1 XKABJYQDMJTNGQ-VIFPVBQESA-N 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- XKLJHFLUAHKGGU-UHFFFAOYSA-N nitrous amide Chemical compound ON=N XKLJHFLUAHKGGU-UHFFFAOYSA-N 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000019645 odor Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- YPZRWBKMTBYPTK-UHFFFAOYSA-N oxidized gamma-L-glutamyl-L-cysteinylglycine Natural products OC(=O)C(N)CCC(=O)NC(C(=O)NCC(O)=O)CSSCC(C(=O)NCC(O)=O)NC(=O)CCC(N)C(O)=O YPZRWBKMTBYPTK-UHFFFAOYSA-N 0.000 description 1
- 239000011236 particulate material Substances 0.000 description 1
- 235000015927 pasta Nutrition 0.000 description 1
- 230000001991 pathophysiological effect Effects 0.000 description 1
- NMHMNPHRMNGLLB-UHFFFAOYSA-N phloretic acid Chemical compound OC(=O)CCC1=CC=C(O)C=C1 NMHMNPHRMNGLLB-UHFFFAOYSA-N 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 229920006254 polymer film Polymers 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000012286 potassium permanganate Substances 0.000 description 1
- 150000003142 primary aromatic amines Chemical class 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 238000013207 serial dilution Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 229950000244 sulfanilic acid Drugs 0.000 description 1
- 231100000606 suspected carcinogen Toxicity 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000036367 tooth discoloration Effects 0.000 description 1
- 231100000186 toxicological potential Toxicity 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 238000001665 trituration Methods 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
- 210000002268 wool Anatomy 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- 239000011592 zinc chloride Substances 0.000 description 1
- 235000005074 zinc chloride Nutrition 0.000 description 1
- 229960001939 zinc chloride Drugs 0.000 description 1
- MLVWCBYTEFCFSG-UHFFFAOYSA-L zinc;dithiocyanate Chemical compound [Zn+2].[S-]C#N.[S-]C#N MLVWCBYTEFCFSG-UHFFFAOYSA-L 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24D—CIGARS; CIGARETTES; TOBACCO SMOKE FILTERS; MOUTHPIECES FOR CIGARS OR CIGARETTES; MANUFACTURE OF TOBACCO SMOKE FILTERS OR MOUTHPIECES
- A24D3/00—Tobacco smoke filters, e.g. filter-tips, filtering inserts; Filters specially adapted for simulated smoking devices; Mouthpieces for cigars or cigarettes
- A24D3/06—Use of materials for tobacco smoke filters
- A24D3/08—Use of materials for tobacco smoke filters of organic materials as carrier or major constituent
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24D—CIGARS; CIGARETTES; TOBACCO SMOKE FILTERS; MOUTHPIECES FOR CIGARS OR CIGARETTES; MANUFACTURE OF TOBACCO SMOKE FILTERS OR MOUTHPIECES
- A24D3/00—Tobacco smoke filters, e.g. filter-tips, filtering inserts; Filters specially adapted for simulated smoking devices; Mouthpieces for cigars or cigarettes
- A24D3/06—Use of materials for tobacco smoke filters
- A24D3/14—Use of materials for tobacco smoke filters of organic materials as additive
Landscapes
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Cigarettes, Filters, And Manufacturing Of Filters (AREA)
- Manufacture Of Tobacco Products (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US2000/017452 WO2002000046A1 (en) | 2000-06-26 | 2000-06-26 | Methods, agents and devices for removing nucleophilic toxins from tobacco and tobacco smoke |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2286026T3 true ES2286026T3 (es) | 2007-12-01 |
Family
ID=21741534
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES00941705T Expired - Lifetime ES2286026T3 (es) | 2000-06-26 | 2000-06-26 | Metodos y dispositivos para eliminar las toxinas nucleofilas del tabaco y del humo del tabaco. |
Country Status (13)
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1585474B1 (en) * | 2003-01-15 | 2010-11-10 | Stryker Corporation | Ambulance cot loading and unloading device |
| EP1856991B1 (en) * | 2005-02-02 | 2014-12-31 | Daicel Chemical Industries, Ltd. | Cigarette filter material and cigarette filter |
| JP4739875B2 (ja) * | 2005-09-13 | 2011-08-03 | ダイセル化学工業株式会社 | たばこフィルターの製造方法 |
| DE102008011671B4 (de) * | 2008-02-28 | 2012-04-26 | Gunther Krieg | Verfahren zur Erkennung von Zigarettenkippen und Zigarettenasche in Hohlkörpern, insbesondere Getränkeflaschen |
| US8952038B2 (en) * | 2010-03-26 | 2015-02-10 | Philip Morris Usa Inc. | Inhibition of undesired sensory effects by the compound camphor |
| IT1404015B1 (it) * | 2011-02-04 | 2013-11-08 | Hsd Holding Smart Device S R L | Uso di un polimero di destrano reticolato come filtro contro l'inalazione di sostanze nocive per la salute |
| JP5882775B2 (ja) * | 2012-02-13 | 2016-03-09 | 株式会社Adeka | セルロース系樹脂組成物及びフィルム |
| ES2935037T3 (es) * | 2013-09-06 | 2023-03-01 | Massachusetts Inst Technology | Materiales de filtro que incluyen celulosa funcionalizada |
| US10383369B2 (en) * | 2017-06-07 | 2019-08-20 | Rai Strategic Holdings, Inc. | Fibrous filtration material for electronic smoking article |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3063892A (en) * | 1959-10-14 | 1962-11-13 | United Shoe Machinery Corp | Preparation of hide fiber |
| US3346519A (en) * | 1964-11-12 | 1967-10-10 | Hawley Products Co | Process of adhering anionic and non-ionic substances to anionic substances |
| DE2230118A1 (de) * | 1972-06-21 | 1974-01-24 | Heinrich Borgwaldt Fa | Verfahren zur herstellung von filtern fuer tabakwaren |
| DE3820089A1 (de) * | 1988-06-13 | 1989-12-14 | Bat Cigarettenfab Gmbh | Verfahren zur impraegnierung von fasern eines tabakrauchfilters mit di- oder polycarbonsaeuren bzw. anhydriden derselben |
| US5706833A (en) * | 1993-07-13 | 1998-01-13 | Daicel Chemical Industries, Ltd. | Tobacco filters and method of producing the same |
| DE4416101C2 (de) * | 1994-04-19 | 1997-06-12 | Reemtsma H F & Ph | Tabakerzeugnisse oder Tabakerzeugnissen ähnliche Waren mit antioxidativ wirkenden Naturstoffen und Verfahren zur Herstellung derselben |
| US5850840A (en) * | 1995-11-15 | 1998-12-22 | Alteon Inc. | Methods for measurement and treatment predicated on the presence of advanced glycosylation endproducts in tobacco and its combustion byproducts |
| US6119701A (en) * | 1998-02-13 | 2000-09-19 | Cerami Consulting Corp. | Methods, agents and devices for removing nucleophilic toxins from tobacco and tobacco smoke |
-
2000
- 2000-06-26 HK HK03104807.2A patent/HK1052440A1/zh unknown
- 2000-06-26 EP EP00941705A patent/EP1309253B1/en not_active Expired - Lifetime
- 2000-06-26 DE DE60034968T patent/DE60034968T2/de not_active Expired - Fee Related
- 2000-06-26 BR BRPI0017258-8A patent/BR0017258B1/pt not_active IP Right Cessation
- 2000-06-26 WO PCT/US2000/017452 patent/WO2002000046A1/en active IP Right Grant
- 2000-06-26 JP JP2002504839A patent/JP4447218B2/ja not_active Expired - Fee Related
- 2000-06-26 AU AU2000256373A patent/AU2000256373A1/en not_active Abandoned
- 2000-06-26 CA CA002414377A patent/CA2414377A1/en not_active Abandoned
- 2000-06-26 AT AT00941705T patent/ATE362718T1/de not_active IP Right Cessation
- 2000-06-26 ES ES00941705T patent/ES2286026T3/es not_active Expired - Lifetime
- 2000-06-26 MX MXPA03000125A patent/MXPA03000125A/es active IP Right Grant
- 2000-06-26 CN CNB008197873A patent/CN1271960C/zh not_active Expired - Fee Related
- 2000-06-26 DK DK00941705T patent/DK1309253T3/da active
Also Published As
| Publication number | Publication date |
|---|---|
| EP1309253B1 (en) | 2007-05-23 |
| MXPA03000125A (es) | 2004-12-06 |
| JP4447218B2 (ja) | 2010-04-07 |
| EP1309253A1 (en) | 2003-05-14 |
| CN1271960C (zh) | 2006-08-30 |
| DE60034968D1 (de) | 2007-07-05 |
| BR0017258B1 (pt) | 2011-03-22 |
| HK1052440A1 (zh) | 2003-09-19 |
| CN1454063A (zh) | 2003-11-05 |
| ATE362718T1 (de) | 2007-06-15 |
| CA2414377A1 (en) | 2002-01-03 |
| DE60034968T2 (de) | 2008-01-24 |
| WO2002000046A1 (en) | 2002-01-03 |
| DK1309253T3 (da) | 2007-09-17 |
| JP2004500901A (ja) | 2004-01-15 |
| BR0017258A (pt) | 2004-01-06 |
| AU2000256373A1 (en) | 2002-03-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6119701A (en) | Methods, agents and devices for removing nucleophilic toxins from tobacco and tobacco smoke | |
| US6615843B2 (en) | Tobacco smoke filter and relative composition made of antioxidant and mineral substances | |
| RU2123271C1 (ru) | Способ изготовления фильтра для табачного дыма, фильтр, сигарета, способ фильтрования табачного дыма | |
| US6615842B1 (en) | Methods for removing nucleophilic toxins from tobacco smoke | |
| JP3966856B2 (ja) | タバコ主流煙からｐ−ベンゾセミキノンを減少させる活性炭フィルタ | |
| ES2286026T3 (es) | Metodos y dispositivos para eliminar las toxinas nucleofilas del tabaco y del humo del tabaco. | |
| PT756461E (pt) | Produtos do tabaco ou artigos semelhantes contendo substancias naturais com propriedades antioxidantes e processo para producao dos mesmos | |
| US20090126747A1 (en) | Plant extracts and uses thereof in filter systems | |
| US20040045566A1 (en) | Tobacco smoke filter and relative composition made of antioxidant and mineral substances | |
| Rylander | Pulmonary cell responses to inhaled cigarette smoke | |
| McGrath et al. | Real-time measurement of inhaled and exhaled cigarette smoke: Implications for dose | |
| US11730189B2 (en) | Cigarette filter containing alginite | |
| WO2017187211A1 (en) | New cigarette filter | |
| JPH044558Y2 (enrdf_load_stackoverflow) | ||
| Dalhamn | CHRONIC PULMONARY DISEASE-THE ETIOLOGICAL FACTORS IN SMOKE | |
| JPH02100663A (ja) | たばこ煙用フィルター | |
| CN1907156A (zh) | 从烟草和烟草烟雾中除去亲核毒素的装置 | |
| Dalhamn | for instance the mucus transport, the ciliary activity, and the free lung cells are | |
| Ansari et al. | Tobacco Smoking: A Birds Eye View | |
| CN101238913A (zh) | 一种有效截留重金属元素的卷烟滤嘴及其制造方法 | |
| CZ58996A3 (cs) | Způsob odstraňování škodlivých oxidačních a karcinogenních těkavých nitrososloučenin z cigaretového kouře za použití biologických látek |